LexisNexis® Legal Newsroom
Kos Pharmaceuticals Pays $41M For Kickbacks, Off-Label Promotion Of Cholesterol Drugs

BATON ROUGE, La. - (Mealey's) The Kos Pharmaceuticals subsidiary of Abbott Laboratories Inc. on Dec. 7 entered into a deferred prosecution agreement and agreed to pay a total of $41 million in criminal penalties and False Claims Act settlement for paying kickbacks to two Louisiana physicians to prescribe...

Merck To Pay $688 Million To Settle 2 Securities Class Action Lawsuits

WHITEHOUSE STATION, N.J. - (Mealey's) Merck and Co. Inc. will pay $688 million to settle two securities class action lawsuits filed in New Jersey federal court alleging that the drug maker and others failed to disclose adverse results of a clinical trial for two cholesterol drugs Merck was developing...